Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: Diebetes Mellitus, Type 2
Interventions: Drug: Linagliptin; Drug: Placebo; Drug: Glimepiride
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Gestational Diabetes Mellitus
Interventions: Drug: Metformin; Drug: Insulin
Sponsor: University of Oulu
Completed - verified March 2010
Condition: Contraception
Interventions: Drug: Desogestrel-Ethinyl Estradiol contraceptive pill; Drug: Etonogestrel-Ethinyl Estradiol vaginal ring; Drug: Norelgestromin-Ethinyl Estradiol contraceptive patch
Sponsor: University of Oulu
Recruiting - verified March 2010
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIBW 2992; Drug: Investigator´s choice of chemotherapy
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Conditions: Gastric Emptying; Healthy
Interventions: Drug: Dexmedetomidine; Drug: Morphine; Drug: Placebo
Sponsors: University of Turku; Helsinki University
Recruiting - verified March 2010
Condition: Hypercholesterol
Intervention: Dietary Supplement: Rye-2008
Sponsors: Helsinki University; Samfundet Folkhälsan; Sigrid Jusélius Foundation; Fazer Bakeries
Completed - verified March 2010
Conditions: Biliary Stricture; Chronic Pancreatitis
Intervention:
Sponsors: Helsinki University Central Hospital; University of Turku; Oulu University Hospital
Recruiting - verified January 2010
Conditions: Obstructive Sleep Apnea; Obesity
Interventions: Procedure: Bariatric surgery; Device: Continuous positive airway pressure
Sponsors: Kuopio University Hospital; Helsinki University Central Hospital; Turku University Hospital; Oulu University Hospital; Vaasa Central Hospital, Vaasa, Finland; National Institute for Health and Welfare, Finland; Helsinki Sleep Clinic; Päijät-Häme Central Hospital,Lahti
Not yet recruiting - verified March 2010
Condition: Acute Coronary Syndrome
Intervention: Device: CFR
Sponsor: The Hospital District of Satakunta
Recruiting - verified March 2010
Condition: Acute Coronary Syndrome
Interventions: Device: OCT; Device: OCT
Sponsor: The Hospital District of Satakunta
Recruiting - verified March 2010
Condition: Endoscopic Retrograde Cholangiopancreatography
Interventions: Device: infusion pump; Device: infusion pump for patient-controlled sedation; Drug: propofol; Drug: fentanyl; Drug: sedative mixture; Drug: remifentanil hydrochlorid
Sponsor: Helsinki University Central Hospital
Completed - verified December 2008
Conditions: Anaesthesia; Surgery
Intervention:
Sponsor: Tampere University Hospital
Recruiting - verified February 2010
Condition: Anaesthesia
Interventions: Drug: Dexmedetomidine; Drug: Saline
Sponsor: Tampere University Hospital
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin detemir (Levemir®); Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Sedation
Interventions: Device: Patient-controlled sedation; Device: Target-controlled infusion
Sponsor: Helsinki University Central Hospital
Recruiting - verified March 2010
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: University of Oulu; Pfizer
Recruiting - verified February 2010
Condition: Chronic Pain
Interventions: Procedure: Open mesh inguinal hernia repair; Device: Prolene Hernia System; Procedure: Lichtenstein technique
Sponsor: Helsinki University Central Hospital
Completed - verified February 2010
Condition: Pancreatitis
Interventions: Drug: Precedex; Drug: sodium chlorid 0,9%
Sponsor: Helsinki University Central Hospital
Recruiting - verified August 2009
All Locations ... More Countries » ... Finland 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
